SCHEMBL16152287

SCHEMBL16152287

Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCC(O)C2(C)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EED O75530 5/20 1.00
▸ SUZ12 Q15022 5/20 1.00
▸ EZH2 Q15910 5/20 1.00
▸ RBBP4 Q09028 1/20 1.00
▸ RBBP7 Q16576 1/20 1.00
▸ IDO1 P14902 12/20 0.81
▸ TDO2 P48775 11/20 0.81
▸ HIF1A Q16665 2/20 0.63
▸ EPAS1 Q99814 2/20 0.63
▸ KDM4E B2RXH2 1/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ CES2 O00748 1/20 0.63
▸ APAF1 O14727 1/20 0.63
▸ TERT O14746 1/20 0.63
▸ ALDH1A1 P00352 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ TP53 P04637 1/20 0.63
▸ POLB P06746 1/20 0.63
▸ MAPT P10636 1/20 0.63
▸ AKR1B1 P15121 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14417701 1.00 EED (1.00) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL14417695 1.00 EED (1.00) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL30923422 0.90 IDO1 (1.00) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL20458626 0.85 EED (0.74) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL16152326 0.80 EED (0.78) EEDSUZ12EZH2RBBP4RBBP7
Tanshinone Iia SCHEMBL2026738 0.77 EED (1.00) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL30017207 0.76 IDO1 (1.00) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL30978884 0.75 IDO1 (0.61) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL29539317 0.75 IDO1 (0.77) EEDSUZ12EZH2RBBP4RBBP7
SCHEMBL16152283 0.75 EED (0.76) EEDSUZ12EZH2RBBP4RBBP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2786990-B1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO LTD (CN) 2018-08-08 — — EP disclosed
US-9771343-B2 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 — — US disclosed
US-9771343-B2 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 — — US disclosed
US-9328083-B2 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2016-05-03 — — US disclosed
US-9328083-B2 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2016-05-03 — — US disclosed
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2015-05-07 — — US disclosed
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2015-05-07 — — US disclosed
US-20140336249-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2014-11-13 — — US disclosed
US-20140336249-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2014-11-13 — — US disclosed
EP-2786989-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) 2014-10-08 — — EP disclosed
EP-2786990-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) 2014-10-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126552-A1 2-AMINATED METHYLENE OR 2-ESTERIFIED METHYLENE TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF NQO1, NFE2L2, NOS2 EED 2852/4885SUZ12 2979/4885EZH2 1525/4885
US-20140336249-A1 2-ALKYL-OR-ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, AND PREPARATION METHOD AND APPLICATION THEREOF CYP2A7, TBXAS1, CYP2J2 EED 2035/4885SUZ12 1083/4885EZH2 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback